For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.
Thesis
Claroty secures cyber-physical systems across industrial (OT), healthcare (IoMT), and broader connected-device (XIoT) environments — asset visibility, exposure management, threat detection, and secure remote access for the systems that run physical operations. Its healthcare expansion (Medigate) broadened it beyond pure industrial into one of the largest cyber-physical install bases.
The investment case is breadth across the cyber-physical security category — industrial plus healthcare — at meaningful scale ahead of a likely IPO. As a private name it has no market cap here; coverage conviction reflects that position. Risks: overlap and competition with Armis, Dragos, Nozomi, and Microsoft; rich private valuation; and long OT/healthcare sales cycles.
Catalysts
- ARR growth and IPO timing
- Healthcare (IoMT) and industrial customer expansion
- xDome platform consolidation across asset types
- Competitive position vs. Armis / Dragos